Skip to main content
ConductScienceScienceDex
NIH funding notice PAR-18-889

Limited Competition: Renewal of, and Revisions to, the Alzheimer's Disease Genetics Consortium (U01 Clinical Trial Not Allowed)

Closed on September 7, 2021.

Posted
August 3, 2018
Close date
September 7, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,145,973 in first-year total cost, median $4,145,973.

Most frequent study sections

  1. Basic Neuroscience of Aging Study Section[NIA-N]1

Most frequent institutions

  1. UNIVERSITY OF PENNSYLVANIA1
Competing awards under PAR-18-889 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Alzheimer's Disease Genetics Consortium2U01AG032984-11SCHELLENBERG, GERARD DAVIDUNIVERSITY OF PENNSYLVANIA, PA$4,145,973NIA

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

Start your CVHow the NIH biosketch works
PAR-18-889: Limited Competition: Renewal of, and Revisions to, the Alzheimer's Disease Genetics Consortium (U01 Clinical Trial Not Allowed) | ScienceDex | ConductScience